Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iSPOT-D trial in major depressive disorder
NL-OMON32293Phase 4Active, not recruiting
- Sponsor
- Brain Resource
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of escitalopram, sertraline and venlafaxine in major depressive disorder (MDD) (4 arms), sponsored by Brain Resource. Primary endpoints: Psychological test markers, Cognitive test markers and 5 more. Started Dec 2008; status: active, not recruiting.
02
Drugs
escitalopramsertralinevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON32293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32293.